Related Experiment Videos
Effective RES blood flow changes in children with homozygous beta-thalassemia in relation to blood transfusion
Insights
Blood transfusions in children with thalassemia significantly increase reticuloendothelial system (RES) blood flow, despite spleen size reduction. This suggests RES blood flow changes are linked to intrasplenic circulatory capacity in thalassemia patients.
Area of Science:
- Hematology
- Pediatrics
- Radiology
Background:
- Thalassemia is a group of inherited blood disorders characterized by reduced hemoglobin production.
- Enlarged spleen (splenomegaly) and altered blood flow are common in thalassemia patients.
- Blood transfusions are a primary treatment, aiming to improve oxygen-carrying capacity and manage complications.
Purpose of the Study:
- To investigate the impact of blood transfusions on reticuloendothelial system (RES) blood flow in children with thalassemia.
- To explore the relationship between post-transfusion spleen size diminution and changes in RES blood flow.
Main Methods:
- Denatured radioiodinated human serum albumin (DHA) clearance studies were performed in 16 children with thalassemia.
- Measurements were taken before and 7-10 days after blood transfusion.
- DHA plasma clearance rate was analyzed to assess RES blood flow.
Main Results:
- A statistically significant increase (P < 0.001) in DHA plasma clearance rate was observed 7-10 days post-transfusion.
- This indicates an increased blood flow to the effective RES.
- Concurrently, a reduction in spleen size was noted after transfusion.
Conclusions:
- Blood transfusion in thalassemic children leads to enhanced effective RES blood flow.
- The observed increase in RES blood flow is associated with a decrease in spleen size.
- Changes in effective RES blood flow are likely directly related to alterations in intrasplenic circulatory capacity.
Abstract:
Denatured radioiodinated human serum albumin (DHA) clearance studies at a dose of 1 mg/kg body wt., were carried out in 16 thalassemic children, prior to and 7-10 days following blood transfusion, to investigate changes of the effective RES blood flow which might accompany the posttransfusion spleen size diminution. A statistically significant increase (P less than 0.001) of the DHA plasma clearance rate was observed 7-10 days following blood transfusion denoting an increase of the blood flow to the effective RES while at the same time the spleen diminished in size. It is suggested that changes in the effective RES blood flow in these patients are directly related to changes in the intrasplenic circulatory capacity.